tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Circio CTO Exercises Warrants Amidst RNA Tech Advances

Circio CTO Exercises Warrants Amidst RNA Tech Advances

Targovax ASA (GB:0RIS) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Circio Holding ASA has seen its Chief Technology Officer, Thomas Birkballe Hansen, exercise 46,800 warrants at a price of NOK 0.60 per share, marking a key development in the company’s stock activity. This exercise is part of a larger issuance of 13,864,852 warrants related to a rights issue from July 2024. Circio continues to advance its cutting-edge RNA technology and cancer treatment projects, which could offer significant future value.

For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1